third

Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results

CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel…

4 months ago

Draganfly Announces Third Quarter Results of 2025

Vancouver, BC., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”),…

4 months ago

Daily GenAI users see higher pay, job security and productivity – while a third of the global workforce regularly feel overwhelmed: PwC

Compared to infrequent users of GenAI at work, daily users are much more likely to have seen tangible benefits in the…

4 months ago

Bounteous Named to 2025 IDC FinTech Rankings Top 100 for Third Consecutive Year

CHICAGO, Nov. 11, 2025 /PRNewswire/ -- Bounteous, a leading global digital transformation consultancy, has been named to the 2025 IDC FinTech…

4 months ago

Global-e to Announce Financial Results for the Third Quarter 2025 on November 19, 2025

November 04, 2025 17:36 ET  | Source: Global-e Online Ltd PETAH-TIKVA, Israel, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Global-e Online…

5 months ago

Urgently Announces Third Quarter 2025 Earnings Release Date and Conference Call

November 04, 2025 17:21 ET  | Source: Urgent.ly Inc. ASHBURN, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq:…

5 months ago

Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the Third Quarter Ended September 30, 2025

November 04, 2025 17:06 ET  | Source: Topicus.com Inc. TORONTO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in…

5 months ago

Kia Announces 2025 Third Quarter Business Results

Kia posts Q3 revenue of KRW 28.69 trillion, up 8.2% Y/yQ3 global sales of 785,137 units, up 2.8% Y/yQ3 operating…

5 months ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

5 months ago

Cellectis to Report Third Quarter Financial Results on November 7, 2025

NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company…

5 months ago